Ruth Dobson

Ground-breaking research at the Centre for Preventive Neurology In 2017, we funded the Preventive Neurology Unit, which has since expanded to become a Centre - the first of its kind in the UK.

A lovely review of some of the things that we have done over the past 7 years @preventiveneur1.bsky.social It’s been a real privilege and joy to do this with our team. Huge thanks to Bart’s Charity for the belief and support. www.bartscharity.org.uk/our-news/gro...

It's been a busy time in the MS group in the Centre for Preventive Neurology! We've put together a newsletter to update where we're up to, opportunities to input into and take part in research, and highlight some of our fantastic PhD students. mailchi.mp/4672ff6ce37d...

First of 8 parkruns in 15 days for us - this one definitely had an over-representation of Professors of Neurology/Neuroscience (I counted 3)

Pregnancy and Infant Outcomes in Women With Multiple Sclerosis Treated With Ocrelizumab | Neurology Neuroimmunology & Neuroinflammation Background and ObjectivesOcrelizumab labeling advises contraception for women during treatment and for 6–12 months thereafter. Because pregnancies may occur during this time, it is critical to underst...

A paper to be proud of from a fab team. ocrelizumab pregnancy registry data, with over 3000 recorded pregnancies, >800 treated within 3 months of pregnancy and >500 of those with outcomes. We need this kind of data to improve shared decision making around pregnancy.
www.neurology.org/doi/10.1212/...

Coffee one day would be lovely. More importantly, I hope you can work out which eras are missing (mainly because angles and fondant icing is not fun).

It’s not been the greatest couple of weeks at work for various reasons (although lots of exciting things just starting to fall into place, so hopefully a temporary blip). The practice for my back up career is going ok though

Using disease-modifying treatments in multiple sclerosis: Association of British Neurologists (ABN) 2024 guidance The Association of British Neurologists last published guidelines on disease-modifying treatment (DMT) in multiple sclerosis (MS) in 2015. Since then, additional DMTs have been licensed and approved f...

So pleased (relieved?) to see these out. We’ve tried to really nail down consensus principles that actually mean something in clinical practice. The result of lots of hard work by many, particularly Waqar Rashid. pn.bmj.com/content/earl...

iWiMS Parental Grant View this form on Formsite

🧪ACTRIMS’ partner organization, International Women in Multiple Sclerosis (iWiMS), is providing 5 travel grants to investigators with young children to cover the costs of childcare during #ACTRIMS2025. Apply here: fs2.formsite.com/1FItkk/w3t1c...

Really excited to be coming to San Diego and sharing the stage with you both - it should be a great session!

Trying to work out this new platform… tricky to know how to start…